The FDA AI tool Elsa was supposed to streamline drug approvals. Instead, insiders say it invents non-existent studies and misrepresents research. Staff have sidelined the tool for core review work due to frequent hallucinations and unreliable outputs. What Elsa Was Meant to Do The FDA launched Elsa in early June to boost efficiency across the…